Oroxylin A alleviates pyroptosis and apoptosis in human corneal epithelial cells under hyperosmotic stress by activating the SIRT3-SOD2/HIF-1α pathway
Experimental Eye Research · 2025
DOI: 10.1016/j.exer.2025.110345 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Eye Research, 2025. Verfasst von Xueqing Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, The Affiliated Hospital of Qingdao University, No. 16 Jiangsu Road, Qingdao, Shandong Province, 266003, China. Hauptthemen laut MEDLINE: Epithelium, Corneal, Apoptosis, Flavonoids, Hypoxia-Inducible Factor 1, alpha Subunit. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: Department of Health of Shandong Province, Medical and Health Science and Technology Development Project of Shandong Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Dry eye disease (DED) is a common ocular surface problem. Ocular surface inflammation and oxidative stress triggered by increased tear osmolarity are crucial pathogeneses of DED. Oroxylin A (OA) extracted from Scutellaria baicalensis exhibits anti-inflammatory, antioxidant, and cell protective properties. The aim of this study was to determine the protective effect and explore the potential mechanisms of OA on hyperosmotic stress-induced human corneal epithelial cells (HCECs). In this study, we demonstrated that OA exhibited a marked protective effect on hyperosmolarity-induced HCEC damage, including improving cell viability and decreasing lactate dehydrogenase release. Furthermore, OA reduced the expression of proinflammatory cytokines (IL-6, IL-1β, and TNF-α) and the generation of oxidative stress-related markers (ROS and NO) in hyperosmotic stress-induced HCECs. In addition, OA decreased HCEC pyroptosis by decreasing NLRP3, caspase-1, cleaved-caspase-1, and N-GSDMD levels. OA also decreased HCEC apoptosis by enhancing Bcl-2 expression while simultaneously decreasing caspase-3 and Bax levels. Moreover, OA enhanced SIRT3 expression in hyperosmotic stress-induced HCECs. A SIRT3 inhibitor reversed the alleviation of pyroptosis and apoptosis induced by OA. SIRT3 could promote SOD2 expression and inhibit HIF-1α and ROS expression in hyperosmotic stress-induced HCECs. In conclusion, OA exhibits anti-inflammatory and antioxidant properties and can alleviate the pyroptosis and apoptosis of HCECs under hyperosmotic stimulation by activating the SIRT3-SOD2/HIF-1α signaling pathway. Therefore, OA may be a new treatment target for dry eye disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, The Affiliated Hospital of Qingdao University, No. 16 Jiangsu Road, Qingdao, Shandong Province, 266003, China.
- Department of Ophthalmology, The Affiliated Hospital of Qingdao University, No. 16 Jiangsu Road, Qingdao, Shandong Province, 266003, China. Electronic address: yankehlt@126.com.
Förderung
- Department of Health of Shandong Province
- Medical and Health Science and Technology Development Project of Shandong Province
- National Natural Science Foundation of China
Zitieren
APA
Liu, X., Xu, Q., Jiang, N., Zheng, W., Yuan, Z., & Hu, L. (2025). Oroxylin A alleviates pyroptosis and apoptosis in human corneal epithelial cells under hyperosmotic stress by activating the SIRT3-SOD2/HIF-1α pathway. Experimental Eye Research. https://doi.org/10.1016/j.exer.2025.110345
Vancouver
Liu X, Xu Q, Jiang N, Zheng W, Yuan Z, Hu L. Oroxylin A alleviates pyroptosis and apoptosis in human corneal epithelial cells under hyperosmotic stress by activating the SIRT3-SOD2/HIF-1α pathway. Experimental Eye Research. 2025. doi:10.1016/j.exer.2025.110345
BibTeX
@article{Liu2025,
author = {Liu, Xueqing and Xu, Qiang and Jiang, Nan and Zheng, Wendan and Yuan, Ziteng and Hu, Liting},
title = {Oroxylin A alleviates pyroptosis and apoptosis in human corneal epithelial cells under hyperosmotic stress by activating the SIRT3-SOD2/HIF-1α pathway},
journal = {Experimental Eye Research},
year = {2025},
doi = {10.1016/j.exer.2025.110345}
}
EUVIMED